FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
DRI Hydrocodone Assay
K Number: K173195
·
Decision Feb 13, 2018
Classifications
1
FEI Numbers
100
Registration Numbers
100
Same Product Code
214
Applicant Total
21
Review Days
134
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- DRI Hydrocodone Assay
- K Number
- K173195
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3650
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Microgenics Corporation
- Date Received
- October 2, 2017
- Decision Date
- February 13, 2018
- Product Code
- DJG
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DJG | Enzyme Immunoassay, Opiates | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DJG), ordered by most recent decision date.
Labcorp Fentanyl Urine Visual Test
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Evidence MultiSTAT DOA Urine MultiPlex
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Buprenorphine II Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
SEFRIA Hydrocodone Oral Fluid
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative; Healgen® Immunofluorescence Analyzer (OG-H180)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Fentanyl III Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Microgenics Corporation
| K Number | Device Name | ||
|---|---|---|---|
| K243498 | Alinity c Benzodiazepines Reagent Kit | Dec 11, 2024 | Substantially Equivalent |
| K240670 | DRI Ecstasy Plus Assay | Oct 30, 2024 | Substantially Equivalent |
| K231020 | Alinity c Tricyclic Antidepressants Reagent Kit | Nov 17, 2023 | Substantially Equivalent |
| K231007 | CEDIA Heroin Metabolite (6-AM) Assay | Sep 27, 2023 | Substantially Equivalent |
| K213875 | DRI TM Tricyclics Serum Tox Assay | Dec 21, 2022 | Substantially Equivalent |
| K211973 | DRI Cocaine Metabolite Assay | Sep 24, 2021 | Substantially Equivalent |
| K192943 | CEDIA Heroin Metabolite (6-AM) assay | Dec 16, 2019 | Substantially Equivalent |
| K190968 | CEDIA Benzodiazepine Assay | Dec 9, 2019 | Substantially Equivalent |
| DEN180030 | QMS Plazomicin Immunoassay | Nov 19, 2018 | Unknown |
| K181499 | DRI Cocaine Metabolite Assay | Jul 6, 2018 | Substantially Equivalent |